Invesco Nasdaq Biotechnology ETF company info

What does Invesco Nasdaq Biotechnology ETF do?
Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) is a fund that focuses on the biotechnology sector, aiming to track the investment results of an index composed of biotechnology and pharmaceutical companies listed on the NASDAQ. This ETF enables investors to gain exposure to a broad range of companies involved in the research, development, and distribution of innovative medical treatments and technologies. The main objective of the fund is to replicate the performance of the NASDAQ Biotechnology Index, thereby providing investment results that closely correspond, before fees and expenses, to the performance of its underlying index. Through its investments, the Invesco Nasdaq Biotechnology ETF plays a crucial role in supporting the growth and development of the biotech industry, offering a diversified portfolio that spans various markets and stages of the biotechnology development cycle.
Invesco Nasdaq Biotechnology ETF company media
Company Snapshot

Is Invesco Nasdaq Biotechnology ETF a public or private company?

key
Ownership
Public

How many people does Invesco Nasdaq Biotechnology ETF employ?

people
Employees
5,023

What sector is Invesco Nasdaq Biotechnology ETF in?

pie chart
Sector
ETF

Where is the head office for Invesco Nasdaq Biotechnology ETF?

location pin
Head Office
Atlanta, United States

What year was Invesco Nasdaq Biotechnology ETF founded?

founded flag
Year Founded
2021
What does Invesco Nasdaq Biotechnology ETF specialise in?
/Equity Investment /Asset Management /Biotechnology Sector /Diversified Portfolios /Risk Management /Investment Strategy

What are the products and/or services of Invesco Nasdaq Biotechnology ETF?

Overview of Invesco Nasdaq Biotechnology ETF offerings
Provides diversified exposure to biotechnology and pharmaceutical companies.
Offers potential for long-term capital growth through investments in Nasdaq-listed biotech firms.
Aims for high-risk adjusted returns by investing in innovative healthcare solutions.
Seeks to mirror the performance of the NASDAQ Biotechnology Index.
Facilitates liquidity and accessibility for investors through exchange-traded fund structure.
Employs professional management with expertise in biotech sector investing.